Clinical and Molecular Profiling Can Help in Predicting the Response to Alemtuzumab Treatment in Kidney Transplant Recipients with Severe or Glucocorticoid-Resistant Acute Rejection

D. M. Peelen; M. van der Zwan; M. C. Clahsen-van Groningen; D. A. Mustafa; C. C. Baan; D. A. Hesselink

doi:10.1111/ajt.16847

Clinical and Molecular Profiling Can Help in Predicting the Response to Alemtuzumab Treatment in Kidney Transplant Recipients with Severe or Glucocorticoid-Resistant Acute Rejection

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	350-350
Number of pages	1
Journal	American Journal of Transplantation
Volume	21
DOIs	https://doi.org/10.1111/ajt.16847
Publication status	Published - Jun 2021

Bibliographical note

in: 2021 American Transplant Congress Abstracts: Oral Abstracts

Access to Document

10.1111/ajt.16847

Cite this

Peelen, D. M., van der Zwan, M., Clahsen-van Groningen, M. C., Mustafa, D. A., Baan, C. C., & Hesselink, D. A. (2021). Clinical and Molecular Profiling Can Help in Predicting the Response to Alemtuzumab Treatment in Kidney Transplant Recipients with Severe or Glucocorticoid-Resistant Acute Rejection. American Journal of Transplantation, 21, 350-350. https://doi.org/10.1111/ajt.16847

@article{372e74724b6e42e984a125503522b416,

title = "Clinical and Molecular Profiling Can Help in Predicting the Response to Alemtuzumab Treatment in Kidney Transplant Recipients with Severe or Glucocorticoid-Resistant Acute Rejection",

author = "Peelen, \{D. M.\} and \{van der Zwan\}, M. and \{Clahsen-van Groningen\}, \{M. C.\} and Mustafa, \{D. A.\} and Baan, \{C. C.\} and Hesselink, \{D. A.\}",

note = "in: 2021 American Transplant Congress Abstracts: Oral Abstracts",

year = "2021",

month = jun,

doi = "10.1111/ajt.16847",

language = "English",

volume = "21",

pages = "350--350",

journal = "American Journal of Transplantation",

issn = "1600-6135",

publisher = "Elsevier",

}

Peelen, DM, van der Zwan, M, Clahsen-van Groningen, MC , Mustafa, DA , Baan, CC & Hesselink, DA 2021, 'Clinical and Molecular Profiling Can Help in Predicting the Response to Alemtuzumab Treatment in Kidney Transplant Recipients with Severe or Glucocorticoid-Resistant Acute Rejection', American Journal of Transplantation, vol. 21, pp. 350-350. https://doi.org/10.1111/ajt.16847

Clinical and Molecular Profiling Can Help in Predicting the Response to Alemtuzumab Treatment in Kidney Transplant Recipients with Severe or Glucocorticoid-Resistant Acute Rejection. / Peelen, D. M.; van der Zwan, M.; Clahsen-van Groningen, M. C. et al.
In: American Journal of Transplantation, Vol. 21, 06.2021, p. 350-350.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - Clinical and Molecular Profiling Can Help in Predicting the Response to Alemtuzumab Treatment in Kidney Transplant Recipients with Severe or Glucocorticoid-Resistant Acute Rejection

AU - Peelen, D. M.

AU - van der Zwan, M.

AU - Clahsen-van Groningen, M. C.

AU - Mustafa, D. A.

AU - Baan, C. C.

AU - Hesselink, D. A.

N1 - in: 2021 American Transplant Congress Abstracts: Oral Abstracts

PY - 2021/6

Y1 - 2021/6

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:000705310101136&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1111/ajt.16847

DO - 10.1111/ajt.16847

M3 - Meeting Abstract

SN - 1600-6135

VL - 21

SP - 350

EP - 350

JO - American Journal of Transplantation

JF - American Journal of Transplantation

ER -

Clinical and Molecular Profiling Can Help in Predicting the Response to Alemtuzumab Treatment in Kidney Transplant Recipients with Severe or Glucocorticoid-Resistant Acute Rejection

Bibliographical note

Access to Document

Other files and links

Cite this